Show simple item record

dc.contributor.authorMaurer, Florian P
dc.contributor.authorShubladze, Natalia
dc.contributor.authorKalmambetova, Gulmira
dc.contributor.authorFelker, Irina
dc.contributor.authorKuchukhidze, Giorgi
dc.contributor.authorDrobniewski, Francis
dc.contributor.authorYedilbayev, Askar
dc.contributor.authorEhsani, Soudeh
dc.contributor.authorEuropean Laboratory Initiative on TB, HIV and Viral Hepatitis
dc.contributor.authorAvellon, Ana 
dc.date.accessioned2022-09-21T07:23:51Z
dc.date.available2022-09-21T07:23:51Z
dc.date.issued2021-06
dc.identifier.citationEuro Surveill. 2021 Jun;26(24):2100426.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15004
dc.description.abstractWe assessed the impact of COVID-19 on diagnostic services for tuberculosis (TB) by national reference laboratories in the WHO European Region. Of 35 laboratories, 30 reported declines in TB sample numbers, amounting up to > 50% of the pre-COVID-19 volumes. Sixteen reported reagent or consumable shortages. Nineteen reallocated ressources to SARS-CoV-2 testing, resulting in an overall increase in workload, largely without a concomitant increase in personnel (n = 14). This poses a risk to meeting the 2025 milestones of the End TB Strategy.es_ES
dc.description.sponsorshipFinancial support for this work has been provided by the German Government.es_ES
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC) es_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPCRes_ES
dc.subjectSARS-CoV-2es_ES
dc.subjectDiagnosticses_ES
dc.subject.meshCOVID-19es_ES
dc.subject.meshTuberculosis es_ES
dc.subject.meshCOVID-19 Testinges_ES
dc.subject.meshHumans es_ES
dc.subject.meshLaboratories es_ES
dc.subject.meshPandemics es_ES
dc.subject.meshSARS-CoV-2es_ES
dc.subject.meshWorld Health Organization es_ES
dc.titleImpact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020es_ES
dc.typeArtículoes_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID34142651es_ES
dc.format.volume26es_ES
dc.format.number24es_ES
dc.format.page2100426es_ES
dc.identifier.doi10.2807/1560-7917.ES.2021.26.24.2100426es_ES
dc.contributor.funderGerman Governmentes_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1560-7917es_ES
dc.relation.publisherversionhttp://dx.doi.org/10.2807/1560-7917.ES.2021.26.24.2100426es_ES
dc.identifier.journalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This item is licensed under a: Attribution-NonCommercial-NoDerivatives 4.0 Internacional